Target intelligence / Profile preview

Fibroblasts and surrounding extracellular matrix (None)

Target
None
Molecular classification
Other
01

Overview

Fibroblasts are the principal cells of connective tissue, responsible for secreting and organizing the extracellular matrix (ECM), which consists of proteins such as collagen, elastin, and proteoglycans (Wynn, 2008, J. Clin. Invest. [1]). This system provides the essential structural scaffold for organs and plays a critical role in wound healing and tissue homeostasis (Alberts et al., 2002, Molecular Biology of the Cell [2]). In various diseases, fibroblasts undergo pathological activation into myofibroblasts, leading to the excessive accumulation of ECM, a process known as fibrosis that can result in organ failure (Richeldi et al., 2014, N. Engl. J. Med. [3]). In oncology, the fibroblast-rich stroma or tumor microenvironment acts as a physical and biochemical barrier that promotes tumor growth and hinders the penetration of chemotherapeutic agents (Sahai et al., 2020, Nat. Rev. Cancer [4]). Therapeutic strategies targeting this system involve modulating signaling pathways like TGF-beta or directly degrading matrix components to restore normal tissue architecture and improve drug delivery (Henderson et al., 2013, Nature [5]).

Other names
Connective tissue stromaFibroblast-rich microenvironmentMyofibroblasts and ECMTumor stroma
02

Mechanism of action

Inhibition of fibroblast proliferation and activation via tyrosine kinase or TGF-beta signaling pathways, and enzymatic degradation of extracellular matrix components like collagen.

03

Biological functions

Structural supportWound healingTissue remodelingCell adhesionSignal transduction
04

Disease associations

FibrosisCancerCardiovascular diseaseSclerodermaChronic inflammation
05

Safety considerations

Impaired wound healingTissue fragilitySystemic toxicityPotential for unintended tumor progression due to stroma remodeling
06

Interacting drugs

Nintedanib

5 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (α-SMA)Fibroblast activation protein (FAP)Collagen type IFibronectinPeriostin

Beyond the preview

Go deeper on Fibroblasts and surrounding extracellular matrix (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibroblasts and surrounding extracellular matrix (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call